Position in ELAN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$74,677,512
+$15,240,972 QoQ
Shares Held
3,120,665
+18.8% QoQ
Ownership
0.625%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 90.65667093391954.ToString("F0")%
Shared 0.ToString("F0")%
None 9.343329066080466.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $132,527,619 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (56.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
This page
|
3,120,665 | $74,677,512 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,439,151 | $43,347,228 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
207,096 | $12,274,579 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
124,898 | $1,552,482 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
20,436 | $675,818 |
All Filings in ELAN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,677,512 | 3,120,665 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $59,436,540 | 2,626,449 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $80,043,347 | 3,974,347 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $46,191,758 | 3,234,717 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $8,049,247 | 766,595 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $13,269,047 | 1,095,710 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $15,872,016 | 1,080,464 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $9,121,144 | 632,096 | Shares | Defined | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||